INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 439s ago
HOUSE PTR5h ago
SEC 13F5h ago
ROBINHOOD CHAIN5h ago
SEC FORM 4/Grant or awardVerified data

Gold Kelly reported CAMP

Chief Financial Officer · Camp4 Therapeutics Corp · Camp4 Therapeutics Corp — Stock Option (Right to Buy)

Side
A
Value
—
Shares
215.0K
Price
—
Executed
Apr 1, 2026
Disclosed
Apr 3, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Apr 1 executedApr 3, 2026 disclosed

CAMP · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
9/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Grant or award — administrative, little informational value

  • Relative size+1 / 25

No reported dollar value · new position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · CAMP

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    9
    TD
    Tardiff DanielChief Scientific Officer
    CAMPCamp4 Therapeutics Corp
    Grant or award
    		A—
    170.0K sh
    		Apr 1, 2026Apr 3, 2026
    traded Apr 1, 2026
    		+2dSEC FORM 4

    Evidence

    19
    TD
    Tardiff DanielChief Scientific Officer
    CAMPCamp4 Therapeutics Corp
    Grant or award
    		A—
    145.5K sh
    		Dec 11, 2025Dec 22, 2025
    traded Dec 11, 2025
    		+11dSEC FORM 4

    Evidence

    19
    GK
    Gold KellyChief Financial Officer
    CAMPCamp4 Therapeutics Corp
    Grant or award
    		A—
    190.0K sh
    		Dec 11, 2025Dec 22, 2025
    traded Dec 11, 2025
    		+11dSEC FORM 4

    Evidence

    19
    MJ
    Mandel-Brehm JoshDirector, Chief Executive Officer
    CAMPCamp4 Therapeutics Corp
    Grant or award
    		A—
    425.0K sh
    		Dec 11, 2025Dec 22, 2025
    traded Dec 11, 2025
    		+11dSEC FORM 4

    Evidence

    19
    MY
    Maricich YuriChief Medical Officer
    CAMPCamp4 Therapeutics Corp
    Grant or award
    		A—
    190.0K sh
    		Dec 11, 2025Dec 22, 2025
    traded Dec 11, 2025
    		+11dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0002033333-26-000002
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Apr 1, 2026
    Published
    Apr 3, 2026
    Ingested by INSIDER
    Nov 5, 04:07 UTC
    Last re-read
    Nov 5, 04:07 UTC

    Extracted facts

    Filer
    Gold Kelly
    Role
    Chief Financial Officer
    Transaction
    Grant or awardAs filed: “A”
    Asset
    Camp4 Therapeutics Corp — Stock Option (Right to Buy)
    Ticker
    CAMP
    Shares
    215.0K
    Price per share
    $0
    Execution date (reported)
    Apr 1, 2026
    Owned after transaction
    215.0K shares
    Days from execution to publication
    2

    What this establishes

    Gold Kelly filed this Form 4 reporting a grant or award of CAMP on Apr 1, 2026. It became public on Apr 3, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Chief Financial Officer
    Gold Kellycik:0002033333
    Issuer
    Camp4 Therapeutics Corpcik:0001736730

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.